Amaury Herbet

Title: Amaury Herbet: Innovator in Cancer Research

Introduction

Amaury Herbet is a notable inventor based in Courbevoie, France. He has made significant contributions to the field of cancer research, particularly through his innovative work on antibodies targeting endothelin receptors.

Latest Patents

Amaury Herbet holds 2 patents that focus on antibodies against endothelin receptors. His first patent is for an antibody against the endothelin receptor subtype A, which includes monoclonal antibodies, fragments, or derivatives. This invention is particularly relevant for therapeutic or diagnostic applications in the field of cancers, especially glioblastoma. His second patent involves an antibody directed against the endothelin receptor subtype B, which also includes monoclonal antibodies and their derivatives. This patent similarly addresses therapeutic and diagnostic uses in cancer research.

Career Highlights

Throughout his career, Amaury has worked with prominent organizations such as the Commissariat à L'Énergie Atomique et aux Énergies Alternatives and Université Paris Cité. His work in these institutions has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Amaury has collaborated with notable colleagues, including Frédéric Ducancel and Jean-Philippe Hugnot. These partnerships have further enriched his research endeavors and have led to impactful innovations in the field.

Conclusion

Amaury Herbet's contributions to cancer research through his innovative patents highlight his role as a significant inventor in the scientific community. His work continues to pave the way for advancements in therapeutic and diagnostic applications in oncology.